Cargando…
Dendritic Cell Subsets in Melanoma: Pathophysiology, Clinical Prognosis and Therapeutic Exploitation
SIMPLE SUMMARY: The clinical success of immunotherapies using immune checkpoint blockers deployed in melanoma strongly supports that the immune system can efficiently control tumor development in the long term. Yet, despite unprecedented successes, many patients still experienced relapse or failed t...
Autores principales: | Sosa Cuevas, Eleonora, Saas, Philippe, Aspord, Caroline |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136655/ https://www.ncbi.nlm.nih.gov/pubmed/37190135 http://dx.doi.org/10.3390/cancers15082206 |
Ejemplares similares
-
Immune checkpoints on T and NK cells in the context of HBV infection: Landscape, pathophysiology and therapeutic exploitation
por: Dumolard, Lucile, et al.
Publicado: (2023) -
The melanoma tumor glyco-code impacts human dendritic cells’ functionality and dictates clinical outcomes
por: Sosa Cuevas, Eleonora, et al.
Publicado: (2023) -
Unique CLR expression patterns on circulating and tumor-infiltrating DC subsets correlated with clinical outcome in melanoma patients
por: Sosa Cuevas, Eleonora, et al.
Publicado: (2022) -
Diversification of circulating and tumor‐infiltrating plasmacytoid DCs towards the P3 (CD80(+) PDL1(−))‐pDC subset negatively correlated with clinical outcomes in melanoma patients
por: Sosa Cuevas, Eleonora, et al.
Publicado: (2022) -
The pathophysiological role of dendritic cell subsets in psoriasis
por: Kim, Tae-Gyun, et al.
Publicado: (2014)